Fukumoto, S <br/><br/>
Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.  [electronic resource] 

 -  Circulation research  Nov 1999 
 - 985-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-7330 
<br/><br/><label>Standard No.: </label>10.1161/01.res.85.11.985  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>8-Bromo Cyclic Adenosine Monophosphate--pharmacology<br/>Blotting, Western<br/>CDC2-CDC28 Kinases<br/>Cell Cycle--drug effects<br/>Cells, Cultured<br/>Cyclic AMP--pharmacology<br/>Cyclic GMP--analogs & derivatives<br/>Cyclin D1--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinase 4<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Cyclins--physiology<br/>Enzyme Activation--drug effects<br/>Humans<br/>Muscle, Smooth, Vascular--cytology<br/>Phosphorylation--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins<br/>Umbilical Arteries